Biotech Values

[Robert C Jonson]

If people can't see implications from above, well, good luck in waiting a few years to find out in ph3.


They imply docetaxel is more efficacious by itself than bavi + docetaxel.

They also imply bavituximab causes more bleeding than docetaxel.

But I thought Bavi was a placebo and did no harm.

Whoops, maybe the FDA screwed up and let an unsafe drug proceed to phIII.